A novel synthetic, nonpsychoactive cannabinoid acid (HU‐320) with antiinflammatory properties in murine collagen‐induced arthritis
Open Access
- 5 March 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (3) , 985-998
- https://doi.org/10.1002/art.20050
Abstract
Objective: To explore the antiarthritic potential of a novel synthetic cannabinoid acid, Hebrew University–320 (HU‐320), in the DBA/1 mouse model of arthritis, and to investigate in vitro antiinflammatory and immunosuppressive effects of HU‐320 on macrophages and lymphocytes.Methods: DBA/1 mice were immunized with bovine type II collagen (CII) to induce arthritis and then injected intraperitoneally daily with HU‐320. The effects of treatment on arthritic changes in hind feet were assessed clinically and histologically, and draining lymph node responses to CII were assayed. Murine splenic and human blood lymphocytes were cultured to study the effect of HU‐320 on polyclonal mitogenic stimulation. Macrophage cultures were set up to evaluate in vitro effects of HU‐320 on production of tumor necrosis factor α (TNFα) and reactive oxygen intermediates (ROIs). The effect of HU‐320 administration on lipopolysaccharide‐induced serum TNF levels was assayed using C57BL/6 mice. Bioactive TNF production was measured using BALB/c clone 7 target cells. Evaluation of HU‐320 psychoactivity was performed using established laboratory tests on Sabra mice.Results: Systemic daily administration of 1 and 2 mg/kg HU‐320 ameliorated established CII‐induced arthritis. Hind foot joints of treated mice were protected from pathologic damage. CII‐specific and polyclonal responses of murine and human lymphocytes were down‐modulated. HU‐320 inhibited production of TNF from mouse macrophages and of ROIs from RAW 264.7 cells and suppressed the rise in serum TNF level following endotoxin challenge. HU‐320 administration yielded no adverse psychotropic effects in mice.Conclusion: Our studies show that the novel synthetic cannabinoid acid HU‐320 has strong antiinflammatory and immunosuppressive properties while demonstrating no psychoactive effects. The profound suppressive effects on cellular immune responses and on the production of proinflammatory mediators all indicate its usefulness as a novel nonpsychoactive, synthetic antiinflammatory product.Keywords
This publication has 53 references indexed in Scilit:
- Antigen‐specific lymphocytes enhance nitric oxide production in Mycobacterium bovis BCG‐infected bovine macrophagesImmunology & Cell Biology, 1998
- Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of AdenylylcyclaseJournal of Medicinal Chemistry, 1997
- Anxiolytic effect of cannabidiol derivatives in the elevated plus-mazeGeneral Pharmacology: The Vascular System, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Stimulation of tumor necrosis factor-α production by mycoplasmas and inhibition by dexamethasone in cultured astrocytesBrain Research, 1993
- Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitroInternational Journal of Immunopharmacology, 1991
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980
- Functional macrophage cell lines transformed by abelson leukemia virusCell, 1978
- Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsinBiochemistry, 1972
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964